drugset / Trial / NCT07011992
A Study to Assess the Effects of BPN14770 on Rosuvastatin
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to investigate the effects of BPN14770 on the pharmacokinetics of the breast cancer resistance protein and organic anion transporting polypeptide 1B1 substrate rosuvastatin in healthy adults.
Timeline
- Start
- 2025-07-18
- Primary completion
- 2025-07-31
- Completion
- 2025-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | — | Oral |
| Subject | zatolmilast | Small molecule | — | Oral |
Indications
No indication recorded.